Drug Halves Recurrence for Common Breast Cancer All of the women in the new trial had undergone a standard treatment scenario. First, they received traditional chemotherapy and the drug Herceptin (trastuzumab) — an antibody that targets HER2-positive cancer cells. Then they had surgery to remove any remaining cancer.

Drug Halves Recurrence for Common Breast Cancer
All of the women in the new trial had undergone a standard treatment scenario. First, they received traditional chemotherapy and the drug Herceptin (trastuzumab) — an antibody that targets HER2-positive cancer cells. Then they had surgery to remove any remaining cancer.

Source link

What do you think?

14 points
Upvote Downvote

Written by DailyHealthNews

Comments

Leave a Reply

Loading…

0